NCT06839716Recruiting
Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic Gastrectomy
Prospective Randomized Controlled Study of Ropivacaine-Poloxamer 407 Based Gel Application and TAP Block for Postoperative Pain Management Following Laparoscopic/Robotic Gastrectomy
Source: ClinicalTrials.gov · Last updated 25 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to determine whether Ropivacaine-Poloxamer 407 hydrogel provides non-inferior pain control compared to TAP block for patients undergoing minimally invasive gastrectomy. The results will guide postoperative pain management practices and enhance recovery protocols for gastric cancer surgery.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 134 (estimated)
- First submitted
- 17 Feb 2025
- Start date
- 1 Feb 2025
- Primary completion date
- 1 Feb 2026
- Lead sponsor
- Gangnam Severance Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06839716
What you commit to
- Study type: Interventional
- Planned participants: 134
- From 1 Feb 2025 to the primary completion date, 1 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have undergone preoperative chemotherapy or radiotherapy.
Other illness
- Diagnosis of malignancies other than gastric cancer.
- Uncontrolled diabetes, autoimmune diseases, hypertrophic scars, or keloid history affecting wound healing.
- History of allergy or adverse reactions to Ropivacaine or other local anesthetics.
- Patients with preoperative chronic pain conditions, including CRPS.
- Patients with psychiatric disorders deemed likely to interfere with study participation.
- Patients with severe liver disease, renal disease, or arrhythmia.
Age
- Patients under 19 years of age.
Other
- Presence of ascites or peritoneal metastasis.
- Pregnant women.
- Patients with long-term preoperative use of opioid analgesics.
Who the study is looking for
- Patients with a histologically confirmed diagnosis of gastric adenocarcinoma prior to surgery.
- Patients who have undergone a complete surgical resection (R0 resection).
- Patients with an ASA (American Society of Anesthesiologists) score of 3 or below.
- Patients aged 20 years or older.
- Patients who have undergone laparoscopic or robotic gastrectomy
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gangnam Severance Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.